Project Grant R01DA062181
Award Date 9/1/25
Completion Date 5/31/30
Dollars Obligated $780K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Indiana, USA
Similar Awards
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $431,750 to Rutgers, The State University of New Jersey to conduct research on informing national overdose prevention and treatment strategies for high-risk adolescents. The key objectives of this 2-year project are to: 1) estimate the prevalence of adolescent nonfatal drug overdose and identify high-risk demographic and clinical subgroups,...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $357,806 to the Trustees of Indiana University to conduct research on neuroimaging of instrumental learning networks in adolescent cannabis use treatment. The key objectives are to: 1) identify associations between cannabis use disorder symptomatology and neural activity during instrumental learning, and 2) examine whether neural activity...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to assess the impacts of a 2022 nationwide shortage of immediate-release formulations of amphetamine mixed salts, a class of prescription stimulant medications, on the health outcomes and disparities of youth with Attention-Deficit Hyperactivity Disorder (ADHD). The $729,367 award, granted to The RAND Corporation, will fund a comprehensive research...
- This $720,763 Project Grant award, provided by the National Institute on Drug Abuse (NIDA) under the federal Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the vulnerability to substance use among adolescents participating in the Adolescent Brain Cognitive Development (ABCD) study. The research aims to investigate how demographic, environmental, and psychological factors influence the transition from substance use initiation to regular or heavy use, while...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $3,939,754 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Northern California Institute for Research and Education, Inc. (NCIRE) for the "Stimulant and Polysubstance Use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE)" research program. The goal of this 5-year project, beginning July 15, 2025, is to investigate the role of stimulant...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $608,652 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Scripps Research Institute. The purpose of this 5-year award, with a start date of September 1, 2025, is to conduct data mining and functional validation of the Systematic Characterization of Retroviral Conditions for Health (SCORCH) datasets. The research aims to elucidate the key pathogenic...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $363,310 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Vermont & State Agricultural College (UVM). The grant, titled "The Healthy Brain and Child Development Study's Scientific Training in Addiction Research Techniques Program (HBCD-START)," will provide comprehensive research education and training to prepare investigators to...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $1,445,752 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to New York University School of Medicine. The grant, titled "Characterizing Complex OUD Care Trajectories and Outcomes Following Acute Service Utilization: A Population-Based Data Linkage Study," aims to apply novel research approaches to better understand real-world opioid use disorder (OUD)...
- This $466,500 Project Grant award was provided by the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279). The grant supports research to systematically examine how psychiatric genetic risk factors and substances of abuse interact at molecular and cellular levels. The key objectives are to: (1) Understand how cellular responses to drugs of abuse are affected by genetic loading for psychiatric disorders, and (2) Identify distinct...
- This federal Project Grant award for $188,995.00 was provided by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research at the University of Pittsburgh focused on understanding, preventing, and treating substance use disorders. The project aims to develop novel interventions, explore neuroscientific mechanisms of addiction, and improve treatment strategies. The...